Alerts5.18.20
USPTO Looks to Expedite Patents for COVID-19 Prevention and Treatment
Highlights
The USPTO will be providing free examination of COVID-19 related patent applications for small and micro entities
Expedited examination and issuance of nonprovisional COVID-19 related patent applications to occur within 6-12 months
Patent applications will be accepted beginning July 13, 2020 and are currently capped at 500 submissions
Many public and private entities are seeking to expedite patents related to treating or preventing COVID-19 and the U.S. Patent and Trademark Office (USPTO) is no different. The USPTO’s new COVID-19 Prioritized Examination Pilot Program (PEPP) will allow applicants to obtain an issued patent quicker and at no cost.
Keep Up to Date in a Changing World
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you’re interested in learning more about.
